Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EPHX1 | P07099 | 8/20 | 0.44 |
| ▸ | EPHX2 | P34913 | 5/20 | 0.43 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.43 |
| ▸ | NPC1 | O15118 | 2/20 | 0.43 |
| ▸ | RAB9A | P51151 | 2/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.43 |
| ▸ | MAPT | P10636 | 1/20 | 0.43 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.43 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.43 |
| ▸ | HPGD | P15428 | 2/20 | 0.41 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.41 |
| ▸ | LMNA | P02545 | 1/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11325844 | 0.92 | SMN1; SMN2 (0.48) | EPHX1EPHX2SMN1; SMN2NPC1RAB9A | |
| SCHEMBL29061111 | 0.90 | EPHX2 (0.50) | EPHX1EPHX2SMN1; SMN2ALDH1A1 | |
| SCHEMBL28203533 | 0.89 | TSHR (0.38) | EPHX1EPHX2SMN1; SMN2LMNA | |
| SCHEMBL5932290 | 0.88 | EPHX1 (0.43) | EPHX1EPHX2SMN1; SMN2ALDH1A1KDM4E | |
| SCHEMBL28819069 | 0.85 | NAAA (0.50) | EPHX1EPHX2 | |
| SCHEMBL7086774 | 0.85 | ALDH1A1 (0.56) | EPHX1SMN1; SMN2ALDH1A1MAPTHPGD | |
| SCHEMBL11800669 | 0.84 | NAAA (0.57) | EPHX1EPHX2 | |
| SCHEMBL28866038 | 0.83 | EPHX2 (0.43) | EPHX1EPHX2SMN1; SMN2NPC1RAB9A | |
| SCHEMBL27620716 | 0.83 | EPHX2 (0.43) | EPHX1EPHX2SMN1; SMN2NPC1RAB9A | |
| SCHEMBL28510616 | 0.83 | NAAA (0.49) | EPHX1EPHX2KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024034516-A1 | ELECTROCONDUCTIVE PASTE AND CONNECTION STRUCTURE | 積水化学工業株式会社 | 2024-02-15 | — | — | WO | disclosed |
| US-20100197841-A1 | HYDROXY ACID AMINE SALT, METHOD FOR PRODUCING THE SAME, AND RUBBER COMPOSITION CONTAINING THE SAME | THE YOKOHAMA RUBBER CO., LTD. | 2010-08-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100197841-A1 | HYDROXY ACID AMINE SALT, METHOD FOR PRODUCING THE SAME, AND RUBBER COMPOSITION CONTAINING THE SAME | HRH3, HRH2, HRH4 | EPHX1 107/4885EPHX2 114/4885SMN1; SMN2 2160/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.